144 related articles for article (PubMed ID: 3844972)
41. Effects of cimetidine on various biological activities of human leucocyte interferon and on interferon production in lymphocytes.
Hirai N; Hattori N; Hill NO; Osther K
Tohoku J Exp Med; 1985 Oct; 147(2):199-212. PubMed ID: 2934865
[TBL] [Abstract][Full Text] [Related]
42. Modulation of mouse spleen natural killer (NK) cell activity by beta-interferon, interleukin-1, and prostaglandins.
Voiculescu CL; Rosu L; Rogoz S
Lymphology; 1988 Sep; 21(3):144-51. PubMed ID: 3264360
[TBL] [Abstract][Full Text] [Related]
43. Depressed natural killer cell activity in acute myocardial infarction.
Klarlund K; Pedersen BK; Theander TG; Andersen V
Clin Exp Immunol; 1987 Oct; 70(1):209-16. PubMed ID: 3500813
[TBL] [Abstract][Full Text] [Related]
44. The prognostic significance of natural killer cytotoxicity in patients with colorectal cancer.
Tartter PI; Steinberg B; Barron DM; Martinelli G
Arch Surg; 1987 Nov; 122(11):1264-8. PubMed ID: 3675190
[TBL] [Abstract][Full Text] [Related]
45. Favorable in vitro effects of combined IL-12 and IL-18 treatment on NK cell cytotoxicity and CD25 receptor expression in metastatic melanoma patients.
Mirjačić Martinović K; Babović N; Džodić R; Jurišić V; Matković S; Konjević G
J Transl Med; 2015 Apr; 13():120. PubMed ID: 25889680
[TBL] [Abstract][Full Text] [Related]
46. Comparison of immunomodulative effects of histamine-2 receptor antagonists in gastric cancer patients: focus on the lymphoblastogenesis and cytotoxicity of peripheral blood mononuclear cells.
Hahm KB; Lee SI; Chung JP; Kim WH; Kim JH; Park IS
Int J Immunopharmacol; 1994 Dec; 16(12):985-93. PubMed ID: 7705971
[TBL] [Abstract][Full Text] [Related]
47. Local immune mechanisms in inflammatory bowel disease and colorectal carcinoma. Natural killer cells and their activity.
Gibson PR; Jewell DP
Gastroenterology; 1986 Jan; 90(1):12-9. PubMed ID: 3509998
[TBL] [Abstract][Full Text] [Related]
48. Studies of natural killer activity and augmentation by OK-432 in patients with gynecological malignancies.
Negishi Y; Miura M; Saito M; Sano Y; Akiya K; Fujiwara Y
Gynecol Obstet Invest; 1986; 21(1):40-6. PubMed ID: 3485072
[TBL] [Abstract][Full Text] [Related]
49. Restoration of anti-interleukin-1 depressed natural killer activity by human recombinant interferon alpha or gamma, human recombinant interleukin-2 and indomethacin.
Conti P; Reale M; Angeletti PU; Dinarello CA
Int J Immunopharmacol; 1988; 10(8):907-11. PubMed ID: 3145923
[TBL] [Abstract][Full Text] [Related]
50. CD56
Vujanovic L; Chuckran C; Lin Y; Ding F; Sander CA; Santos PM; Lohr J; Mashadi-Hossein A; Warren S; White A; Huang A; Kirkwood JM; Butterfield LH
Front Immunol; 2019; 10():14. PubMed ID: 30761123
[TBL] [Abstract][Full Text] [Related]
51. Antibody-dependent cellular cytotoxicity (ADCC) in colorectal carcinoma. II. Blood group association.
Jones SL; Pihl E; Nind AP; Chalmers PJ; Nairn RC
J Surg Oncol; 1983 Nov; 24(3):229-32. PubMed ID: 6355663
[TBL] [Abstract][Full Text] [Related]
52. In vitro modulation of natural killer cell activity in non-Hodgkin's lymphoma patients after therapy.
Mehta BA; Satam MN; Advani SH; Nadkarni JJ
Cancer Immunol Immunother; 1989; 28(2):148-52. PubMed ID: 2917365
[TBL] [Abstract][Full Text] [Related]
53. Natural killer activity and antibody-dependent cellular cytotoxicity in patients with non-Hodgkin's lymphoma.
Metha BA; Advani SH; Nadkarni SJ
Neoplasma; 1988; 35(1):61-8. PubMed ID: 3352838
[TBL] [Abstract][Full Text] [Related]
54. Comparison of immunomodulative effects of the histamine-2 receptor antagonists cimetidine, ranitidine, and famotidine on peripheral blood mononuclear cells in gastric cancer patients.
Hahm KB; Kim WH; Lee SI; Kang JK; Park IS
Scand J Gastroenterol; 1995 Mar; 30(3):265-71. PubMed ID: 7770717
[TBL] [Abstract][Full Text] [Related]
55. Indomethacin in vitro and in vivo abolishes post-exercise suppression of natural killer cell activity in peripheral blood.
Pedersen BK; Tvede N; Klarlund K; Christensen LD; Hansen FR; Galbo H; Kharazmi A; Halkjaer-Kristensen J
Int J Sports Med; 1990 Apr; 11(2):127-31. PubMed ID: 2338373
[TBL] [Abstract][Full Text] [Related]
56. Regulation of human natural killer cell cytotoxicity by recombinant leukocyte interferon clone A.
Lotzová E; Savary CA; Gutterman JU; Quesada JR; Hersh EM
J Biol Response Mod; 1983; 2(5):482-96. PubMed ID: 6644351
[TBL] [Abstract][Full Text] [Related]
57. Modulation of natural killer and antibody-dependent cellular cytotoxicity by interferon and interleukin-2 in chronic myeloid leukemia patients in remission.
Dabholkar M; Tatake R; Amin K; Advani S; Gangal S
Oncology; 1989; 46(2):123-7. PubMed ID: 2785254
[TBL] [Abstract][Full Text] [Related]
58. Reduced killer cell activity of lymphocytes from patients with asbestosis.
Kubota M; Kagamimori S; Yokoyama K; Okada A
Br J Ind Med; 1985 Apr; 42(4):276-80. PubMed ID: 3978049
[TBL] [Abstract][Full Text] [Related]
59. The differential effects of human leukocyte pyrogen/lymphocyte-activating factor, T cell growth factor, and interferon on human natural killer activity.
Dempsey RA; Dinarello CA; Mier JW; Rosenwasser LJ; Allegretta M; Brown TE; Parkinson DR
J Immunol; 1982 Dec; 129(6):2504-10. PubMed ID: 6982930
[No Abstract] [Full Text] [Related]
60. Augmentation of natural immunity and correlation with tumor response in melanoma patients treated with human lymphoblastoid interferon.
Neefe JR; Phillips EA; Treat J
Diagn Immunol; 1986; 4(6):299-305. PubMed ID: 3102149
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
